Search results
AbbVie reports positive Phase II ovarian cancer trial data
Clinical Trials Arena via Yahoo Finance· 23 hours agoPhase III CERVINO trial of its investigational product ABBV-383 for relapsed/refractory multiple...
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating...
Benzinga· 5 days agoStrasbourg, France, June 3, 2024, 7:30 a.m. CET – Transgene TNG, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today ...
Melt doses first subject in Phase III trial of non-opioid sedation tablet
Clinical Trials Arena via Yahoo Finance· 1 day agoThe randomised, double-blind, three-arm study is designed to assess the product's safety and...
FDA places full clinical hold on Biomea Fusion’s diabetes trials of BMF-219
Clinical Trials Arena via Yahoo Finance· 1 day agoPhase I/II COVALENT-111 study has completed its Phase I portion where healthy individuals were...
Vir Biotechnology (VIR) Up on Positive Data From HDV Study
Zacks via Yahoo Finance· 2 days agoVir Biotechnology (VIR) rises on upbeat data from its phase II study evaluating tobevibart and...
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Zacks via Yahoo Finance· 18 hours agoBMS-986446 (formerly PRX005) is designed to be a best-in-class anti-tau, MTBR-specific antibody for...
...GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC...
WLNS Lansing· 6 days agoGenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in...
ASCO 2024: STORM presents positive interim Phase I data on RNA inhibitor
Clinical Trials Arena via Yahoo Finance· 5 days agoThe Phase I study was designed to evaluate STC-15’s safety, pharmacokinetics, pharmacodynamics,...
Gilead’s seladelpar shows promise in primary biliary cholangitis trial
Clinical Trials Arena via Yahoo Finance· 2 days agoThe latest development comes after the company announced the progression of subject enrolment in two...
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Zacks via Yahoo Finance· 5 days agoRCUS announce new data from Cohort B of the ARC-9 study. ARC-9 is a phase Ib/II study evaluating the...